Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 236 entries
Sorted by: Best Match Show Resources per page
Technical Advances in Medicinal Chemistry.

ACS combinatorial science

Finn MG.
PMID: 28374995
ACS Comb Sci. 2017 May 08;19(5):277-278. doi: 10.1021/acscombsci.7b00053. Epub 2017 Apr 04.

No abstract available.

Cite
Finn MG. Technical Advances in Medicinal Chemistry. ACS Comb Sci. 2017;19(5):277-278doi: 10.1021/acscombsci.7b00053.
Finn, M. G. (2017). Technical Advances in Medicinal Chemistry. ACS combinatorial science, 19(5), 277-278. https://doi.org/10.1021/acscombsci.7b00053
Finn, M G. "Technical Advances in Medicinal Chemistry." ACS combinatorial science vol. 19,5 (2017): 277-278. doi: https://doi.org/10.1021/acscombsci.7b00053
Finn MG. Technical Advances in Medicinal Chemistry. ACS Comb Sci. 2017 May 08;19(5):277-278. doi: 10.1021/acscombsci.7b00053. Epub 2017 Apr 04. PMID: 28374995.
Copy Download .nbib Format: NLM
[Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Tokiwa H.
PMID: 26329543
Yakugaku Zasshi. 2015;135(9):1001-2. doi: 10.1248/yakushi.15-00175-F.

No abstract available.

Cite
Tokiwa H. [Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category]. Yakugaku Zasshi. 2015;135(9):1001-2doi: 10.1248/yakushi.15-00175-F.
Tokiwa, H. (2015). [Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 135(9), 1001-2. https://doi.org/10.1248/yakushi.15-00175-F
Tokiwa, Hiroaki. "[Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category]." Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan vol. 135,9 (2015): 1001-2. doi: https://doi.org/10.1248/yakushi.15-00175-F
Tokiwa H. [Possibility of New Medicinal Chemistry Based on "Wet-Dry" Interfaced Pharmaceutical Category]. Yakugaku Zasshi. 2015;135(9):1001-2. doi: 10.1248/yakushi.15-00175-F. Japanese. PMID: 26329543.
Copy Download .nbib Format: NLM
How many molecules does it take to tell a story? Case studies, language, and an epistemic view of medicinal chemistry.

ChemMedChem

Stahl M, Baier S.
PMID: 25820774
ChemMedChem. 2015 Jun;10(6):949-56. doi: 10.1002/cmdc.201500091. Epub 2015 Mar 27.

Medicinal chemistry has always been closer to the arts than other disciplines in the natural sciences. Instead of searching for natural laws, medicinal chemistry creates new molecular entities entailing desired pharmaceutical characteristics. While the productive output of medicinal chemistry...

Cite
Stahl M, Baier S. How many molecules does it take to tell a story? Case studies, language, and an epistemic view of medicinal chemistry. ChemMedChem. 2015;10(6):949-56doi: 10.1002/cmdc.201500091.
Stahl, M., & Baier, S. (2015). How many molecules does it take to tell a story? Case studies, language, and an epistemic view of medicinal chemistry. ChemMedChem, 10(6), 949-56. https://doi.org/10.1002/cmdc.201500091
Stahl, Martin, and Baier, Sabine. "How many molecules does it take to tell a story? Case studies, language, and an epistemic view of medicinal chemistry." ChemMedChem vol. 10,6 (2015): 949-56. doi: https://doi.org/10.1002/cmdc.201500091
Stahl M, Baier S. How many molecules does it take to tell a story? Case studies, language, and an epistemic view of medicinal chemistry. ChemMedChem. 2015 Jun;10(6):949-56. doi: 10.1002/cmdc.201500091. Epub 2015 Mar 27. PMID: 25820774.
Copy Download .nbib Format: NLM
Embedding sustainable practices into pharmaceutical R&D: what are the challenges?.

Future medicinal chemistry

Sneddon H.
PMID: 25329193
Future Med Chem. 2014;6(12):1373-6. doi: 10.4155/fmc.14.91.

No abstract available.

Cite
Sneddon H. Embedding sustainable practices into pharmaceutical R&D: what are the challenges?. Future Med Chem. 2014;6(12):1373-6doi: 10.4155/fmc.14.91.
Sneddon, H. (2014). Embedding sustainable practices into pharmaceutical R&D: what are the challenges?. Future medicinal chemistry, 6(12), 1373-6. https://doi.org/10.4155/fmc.14.91
Sneddon, Helen. "Embedding sustainable practices into pharmaceutical R&D: what are the challenges?." Future medicinal chemistry vol. 6,12 (2014): 1373-6. doi: https://doi.org/10.4155/fmc.14.91
Sneddon H. Embedding sustainable practices into pharmaceutical R&D: what are the challenges?. Future Med Chem. 2014;6(12):1373-6. doi: 10.4155/fmc.14.91. PMID: 25329193.
Copy Download .nbib Format: NLM
Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications.

Pharmaceutical research

Bugay DE.
PMID: 8464803
Pharm Res. 1993 Mar;10(3):317-27. doi: 10.1023/a:1018967717781.

The theory of solid-state nuclear magnetic resonance (NMR) spectroscopy is reviewed, with specific discussions of magnetic interactions in the solid state. Each magnetic interaction (Zeeman, dipole-dipole, chemical-shift, spin-spin, and quadrupolar) is addressed and manifestations of these interactions in the...

Cite
Bugay DE. Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications. Pharm Res. 1993;10(3):317-27doi: 10.1023/a:1018967717781.
Bugay, D. E. (1993). Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications. Pharmaceutical research, 10(3), 317-27. https://doi.org/10.1023/a:1018967717781
Bugay, D E. "Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications." Pharmaceutical research vol. 10,3 (1993): 317-27. doi: https://doi.org/10.1023/a:1018967717781
Bugay DE. Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications. Pharm Res. 1993 Mar;10(3):317-27. doi: 10.1023/a:1018967717781. PMID: 8464803.
Copy Download .nbib Format: NLM
Inorganic pharmaceutical chemistry: a student-oriented approach to instruction.

American journal of pharmaceutical education

Mackowiak ED, Mackowiak RC, Tuckerman MM.
PMID: 10237120
Am J Pharm Educ. 1975 Aug;39(3):251-4.

No abstract available.

Cite
Mackowiak ED, Mackowiak RC, Tuckerman MM. Inorganic pharmaceutical chemistry: a student-oriented approach to instruction. Am J Pharm Educ. 1975;39(3):251-4
Mackowiak, E. D., Mackowiak, R. C., & Tuckerman, M. M. (1975). Inorganic pharmaceutical chemistry: a student-oriented approach to instruction. American journal of pharmaceutical education, 39(3), 251-4.
Mackowiak, E D, et al. "Inorganic pharmaceutical chemistry: a student-oriented approach to instruction." American journal of pharmaceutical education vol. 39,3 (1975): 251-4.
Mackowiak ED, Mackowiak RC, Tuckerman MM. Inorganic pharmaceutical chemistry: a student-oriented approach to instruction. Am J Pharm Educ. 1975 Aug;39(3):251-4. PMID: 10237120.
Copy Download .nbib Format: NLM
[Pyrazole sulfanilamides. XI. Ethoxy derivatives of phenyl-3-sulfanilamidopyrazole, phenyl-4-sulphanilamidopyrazole, 1-phenyl-5-sulfanilamidopyrazole, 1-phenyl-3-methyl-5-sulfanilamidopyrazole].

Il Farmaco; edizione scientifica

Alberti C, Tironi C.
PMID: 5542665
Farmaco Sci. 1971 Jan;26(1):66-88.

No abstract available.

Cite
Alberti C, Tironi C. Sulfanilammidi pirazoliche. XI. Etossiderivati dell'1-fenil-3-sulfanilammidopirazolo, dell'1-fenil-4-sulfanilammidopirazolo, dell'1-fenil-5-sulfanilammidopirazolo e dell'1-fenyl-3-metil-5-sulfanilammidopirazolo. [Pyrazole sulfanilamides. XI. Ethoxy derivatives of phenyl-3-sulfanilamidopyrazole, phenyl-4-sulphanilamidopyrazole, 1-phenyl-5-sulfanilamidopyrazole, 1-phenyl-3-methyl-5-sulfanilamidopyrazole]. Farmaco Sci. 1971;26(1):66-88
Alberti, C., & Tironi, C. (1971). Sulfanilammidi pirazoliche. XI. Etossiderivati dell'1-fenil-3-sulfanilammidopirazolo, dell'1-fenil-4-sulfanilammidopirazolo, dell'1-fenil-5-sulfanilammidopirazolo e dell'1-fenyl-3-metil-5-sulfanilammidopirazolo. [Pyrazole sulfanilamides. XI. Ethoxy derivatives of phenyl-3-sulfanilamidopyrazole, phenyl-4-sulphanilamidopyrazole, 1-phenyl-5-sulfanilamidopyrazole, 1-phenyl-3-methyl-5-sulfanilamidopyrazole]. Il Farmaco; edizione scientifica, 26(1), 66-88.
Alberti, C, and Tironi, C. "Sulfanilammidi pirazoliche. XI. Etossiderivati dell'1-fenil-3-sulfanilammidopirazolo, dell'1-fenil-4-sulfanilammidopirazolo, dell'1-fenil-5-sulfanilammidopirazolo e dell'1-fenyl-3-metil-5-sulfanilammidopirazolo." [Pyrazole sulfanilamides. XI. Ethoxy derivatives of phenyl-3-sulfanilamidopyrazole, phenyl-4-sulphanilamidopyrazole, 1-phenyl-5-sulfanilamidopyrazole, 1-phenyl-3-methyl-5-sulfanilamidopyrazole]. Il Farmaco; edizione scientifica vol. 26,1 (1971): 66-88.
Alberti C, Tironi C. Sulfanilammidi pirazoliche. XI. Etossiderivati dell'1-fenil-3-sulfanilammidopirazolo, dell'1-fenil-4-sulfanilammidopirazolo, dell'1-fenil-5-sulfanilammidopirazolo e dell'1-fenyl-3-metil-5-sulfanilammidopirazolo. [Pyrazole sulfanilamides. XI. Ethoxy derivatives of phenyl-3-sulfanilamidopyrazole, phenyl-4-sulphanilamidopyrazole, 1-phenyl-5-sulfanilamidopyrazole, 1-phenyl-3-methyl-5-sulfanilamidopyrazole]. Farmaco Sci. 1971 Jan;26(1):66-88. Italian. PMID: 5542665.
Copy Download .nbib Format: NLM
For medicinal purposes.

Nature

Petsko GA.
PMID: 8895592
Nature. 1996 Nov 07;384(6604):7-9. doi: 10.1038/384007a0.

Developments in techniques of pharmaceutical chemistry are poised to revolutionize the design of drugs beyond previous expectations. But what are our current expectations and what does the future hold?

Cite
Petsko GA. For medicinal purposes. Nature. 1996;384(6604):7-9doi: 10.1038/384007a0.
Petsko, G. A. (1996). For medicinal purposes. Nature, 384(6604), 7-9. https://doi.org/10.1038/384007a0
Petsko, G A. "For medicinal purposes." Nature vol. 384,6604 (1996): 7-9. doi: https://doi.org/10.1038/384007a0
Petsko GA. For medicinal purposes. Nature. 1996 Nov 07;384(6604):7-9. doi: 10.1038/384007a0. PMID: 8895592.
Copy Download .nbib Format: NLM
Role of the development scientist in compound lead selection and optimization.

Journal of pharmaceutical sciences

Venkatesh S, Lipper RA.
PMID: 10688744
J Pharm Sci. 2000 Feb;89(2):145-54. doi: 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6.

The R&D process for bringing drugs from discovery laboratories to the marketplace is undergoing rapid change, as enabled by new technologies and as demanded by the global pharmaceutical business environment. One consequence of the accelerated R&D paradigm is a...

Cite
Venkatesh S, Lipper RA. Role of the development scientist in compound lead selection and optimization. J Pharm Sci. 2000;89(2):145-54doi: 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6.
Venkatesh, S., & Lipper, R. A. (2000). Role of the development scientist in compound lead selection and optimization. Journal of pharmaceutical sciences, 89(2), 145-54. https://doi.org/10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6
Venkatesh, S, and Lipper, R A. "Role of the development scientist in compound lead selection and optimization." Journal of pharmaceutical sciences vol. 89,2 (2000): 145-54. doi: https://doi.org/10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6
Venkatesh S, Lipper RA. Role of the development scientist in compound lead selection and optimization. J Pharm Sci. 2000 Feb;89(2):145-54. doi: 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6. PMID: 10688744.
Copy Download .nbib Format: NLM
[On the influence of concentration on the specific rotation ability of different substances also used as drugs].

Pharmazeutische Zentralhalle fur Deutschland

KONKOLY THEGE I, PUNGOR E, SCHULEK E.
PMID: 14410867
Pharm Zentralhalle Dtschl. 1960 May;99:231-40.

No abstract available.

Cite
KONKOLY THEGE I, PUNGOR E, SCHULEK E. [On the influence of concentration on the specific rotation ability of different substances also used as drugs]. Pharm Zentralhalle Dtschl. 1960;99:231-40
KONKOLY THEGE, I., PUNGOR, E., & SCHULEK, E. (1960). [On the influence of concentration on the specific rotation ability of different substances also used as drugs]. Pharmazeutische Zentralhalle fur Deutschland, 99231-40.
KONKOLY THEGE, I, et al. "[On the influence of concentration on the specific rotation ability of different substances also used as drugs]." Pharmazeutische Zentralhalle fur Deutschland vol. 99 (1960): 231-40.
KONKOLY THEGE I, PUNGOR E, SCHULEK E. [On the influence of concentration on the specific rotation ability of different substances also used as drugs]. Pharm Zentralhalle Dtschl. 1960 May;99:231-40. German. PMID: 14410867.
Copy Download .nbib Format: NLM
Molecular size and shape. A review of the light-scattering method applied to some important biological and other macromolecules. Part I.

The Journal of pharmacy and pharmacology

ROBINSON N.
PMID: 14437979
J Pharm Pharmacol. 1960 Mar;12:129-49. doi: 10.1111/j.2042-7158.1960.tb12645.x.

No abstract available.

Cite
ROBINSON N. Molecular size and shape. A review of the light-scattering method applied to some important biological and other macromolecules. Part I. J Pharm Pharmacol. 1960;12:129-49doi: 10.1111/j.2042-7158.1960.tb12645.x.
ROBINSON, N. (1960). Molecular size and shape. A review of the light-scattering method applied to some important biological and other macromolecules. Part I. The Journal of pharmacy and pharmacology, 12129-49. https://doi.org/10.1111/j.2042-7158.1960.tb12645.x
ROBINSON, N. "Molecular size and shape. A review of the light-scattering method applied to some important biological and other macromolecules. Part I." The Journal of pharmacy and pharmacology vol. 12 (1960): 129-49. doi: https://doi.org/10.1111/j.2042-7158.1960.tb12645.x
ROBINSON N. Molecular size and shape. A review of the light-scattering method applied to some important biological and other macromolecules. Part I. J Pharm Pharmacol. 1960 Mar;12:129-49. doi: 10.1111/j.2042-7158.1960.tb12645.x. PMID: 14437979.
Copy Download .nbib Format: NLM
Sequential analysis, screening and serendipity.

Journal of medicinal and pharmaceutical chemistry

LITCHFIELD JT.
PMID: 13762705
J Med Pharm Chem. 1960 Oct;2:469-92. doi: 10.1021/jm50012a001.

No abstract available.

Cite
LITCHFIELD JT. Sequential analysis, screening and serendipity. J Med Pharm Chem. 1960;2:469-92doi: 10.1021/jm50012a001.
LITCHFIELD, J. T. (1960). Sequential analysis, screening and serendipity. Journal of medicinal and pharmaceutical chemistry, 2469-92. https://doi.org/10.1021/jm50012a001
LITCHFIELD, J T. "Sequential analysis, screening and serendipity." Journal of medicinal and pharmaceutical chemistry vol. 2 (1960): 469-92. doi: https://doi.org/10.1021/jm50012a001
LITCHFIELD JT. Sequential analysis, screening and serendipity. J Med Pharm Chem. 1960 Oct;2:469-92. doi: 10.1021/jm50012a001. PMID: 13762705.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 236 entries